Parkinsons drug may slow illness progression study suggests
Levodopa used to treat Parkinsons symptoms might slow disease progression without hastening decline, with brain scans hinting possible cell loss. The NEJM report notes mixed results and calls for further work to confirm effects, while a secondary study shows rivastigmine offers modest help for Parkinsons related dementia.
MENTIONED IN THIS ARTICLE
New England Journal of Medicine
Stanley Fahn
Columbia University Medical Center
J. Timothy Greenamyre
University of Pittsburgh School of Medicine
Greenamore
New drug Arimidex outperforms tamoxifen in preventing breast cancer return
San Antonio doctors report Arimidex superior to tamoxifen for most postmenopausal women after early breast cancer treatment. In a U S study of nearly 2,000 women and 7,300 more abroad, five years of Arimidex reduced recurrence, new cancers in the opposite breast, and spread compared with five years of tamoxifen. The research, funded by AstraZeneca, was presented in Texas and published in The Lancet.
MENTIONED IN THIS ARTICLE
San Antonio
Aman Buzdar
Arimidex
AstraZeneca PLC
Texas
the Lancet
Pfizer Inc
GAO Finds Medicare Help Line Often Unhelpful
The GAO report shows Medicare help line accuracy under 66 percent with 55 of 70 errors on drug card subsidy questions. It cites mis explanations about trunk strength and wheelchair coverage, amid a surge in calls after new drug law.
MENTIONED IN THIS ARTICLE
Washington
Government Accountability Office
GAO
Medicare
Mark McClellan
Gary Karr
Centers For Medicare and Medicaid Services
McClellan
Also Mentioned on This Page
Malcolm Ritter
U.S
United States
Source
Centers For Disease Control and Prevention
University of Texas
M.D. Anderson Cancer Center
Miracle-Ear
Eacla
Tore Othe
Gow Aor Duce
Cenia Mabres
Lawrence Sears
Iowa St
Topeka
Wal-Mart
The
Hearing Aid Center America Trusts
the Nate
Healthy Instinct
Ottawa
Aees
Acm
Juana On
Santa
Allegiance
Cable
Www
Allegiance.tv